HomeCompareLEVOX vs MO

LEVOX vs MO: Dividend Comparison 2026

LEVOX yields 43.96% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LEVOX wins by $209.4K in total portfolio value
10 years
LEVOX
LEVOX
● Live price
43.96%
Share price
$12.78
Annual div
$5.62
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$287.1K
Annual income
$52,433.30
Full LEVOX calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — LEVOX vs MO

📍 LEVOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLEVOXMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LEVOX + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LEVOX pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LEVOX
Annual income on $10K today (after 15% tax)
$3,736.76/yr
After 10yr DRIP, annual income (after tax)
$44,568.31/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, LEVOX beats the other by $19,945.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LEVOX + MO for your $10,000?

LEVOX: 50%MO: 50%
100% MO50/50100% LEVOX
Portfolio after 10yr
$182.4K
Annual income
$40,700.92/yr
Blended yield
22.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

LEVOX
No analyst data
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LEVOX buys
0
MO buys
11
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MO▲ Buy$1,000 - $15,0002025-08-04
Sheri Biggs🏢 House$MO▼ Sell$1,001 - $15,0002025-03-19
Pete Sessions🏢 House$MO▼ Sell$1,001 - $15,0002024-09-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-03-20
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-02-13
Virginia Foxx🏢 House$MO▼ Sell$1,001 - $15,0002024-01-16
Virginia Foxx🏢 House$MO▲ Buy$1,001 - $15,0002024-01-11
Ro Khanna🏢 House$MO▼ Sell$1,001 - $15,0002024-01-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-01-10
Virginia Foxx🏢 House$MO▼ Sell$15,001 - $50,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLEVOXMO
Forward yield43.96%6.27%
Annual dividend / share$5.62$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$287.1K$77.7K
Annual income after 10y$52,433.30$28,968.54
Total dividends collected$221.8K$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LEVOX vs MO ($10,000, DRIP)

YearLEVOX PortfolioLEVOX Income/yrMO PortfolioMO Income/yrGap
1← crossover$15,096$4,396.19$10,558$768.31+$4.5KLEVOX
2$22,355$6,202.40$11,352$1,015.87+$11.0KLEVOX
3$32,504$8,584.00$12,482$1,367.86+$20.0KLEVOX
4$46,444$11,664.46$14,103$1,883.39+$32.3KLEVOX
5$65,272$15,576.52$16,472$2,664.91+$48.8KLEVOX
6$90,299$20,458.86$20,024$3,897.79+$70.3KLEVOX
7$123,072$26,452.01$25,537$5,933.74+$97.5KLEVOX
8$165,381$33,693.84$34,478$9,476.77+$130.9KLEVOX
9$219,273$42,314.83$49,776$16,022.63+$169.5KLEVOX
10$287,055$52,433.30$77,699$28,968.54+$209.4KLEVOX

LEVOX vs MO: Complete Analysis 2026

LEVOXStock

The investment seeks long-term capital appreciation. The Portfolio invests primarily in equity securities, principally common stocks, of U.S. companies of any market capitalization. The Portfolio has a concentrated portfolio of investments, typically investing in 15 to 35 companies with market capitalizations generally greater than $350 million. The Portfolio seeks to outperform broad-based securities market indices, such as the S&P 500® Index, the Russell 1000® Index and the Russell 3000® Index. Under normal circumstances, the Portfolio invests at least 80% of its assets in equity securities of U.S. companies. The fund is non-diversified.

Full LEVOX Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this LEVOX vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LEVOX vs SCHDLEVOX vs JEPILEVOX vs OLEVOX vs KOLEVOX vs MAINLEVOX vs PMLEVOX vs BTILEVOX vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.